Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.


TSX:MSCL - Post by User

Comment by Rodrichon Oct 06, 2017 12:06pm
82 Views
Post# 26786172

RE:RE:Concerns to consider

RE:RE:Concerns to considerI agree with the big concerns indicated by Steve. The share price could become much more cheap.....Who knows?
Rodrich wrote: IMNP share price dropping & dropping. Really bad for IMNP.............
Steve888 wrote:
I personally have the following major concerns to play ICO: (1) Immune Pharmaceuticals Inc. announced that on August 23, 2017, the Company received written notice from the Listing Qualifications Department of The NASDAQ Stock Market LLC that the Company no longer complies with the minimum stockholders' equity requirement under NASDAQ Listing Rule. (Please read the news at: https://web.tmxmoney.com/article.php?newsid=7560944190335575&qm_symbol=IMNP:US ). So, a big question is: will IMNP be delisted??? If IMNP is delisted, it could be a disaster for ICO share price? (2) ICOs cash becomes less and less. Definitely, ICO will run out of its money quickly. If ICO runs out of money, what will happen? Even assume that ICO could successfully refinance, there would a large dilutions. So what will happen on the share price? No doubt, the share price will drop. (3) The drug trials take long time to complete. In addition, nobody knows what will be the results of the trials. If the trial results are bad, then the company may go bankrupt! In this case, all shareholders' money goes zero. So we see the huge risk here. (4) The tax season is coming, there will more likely large share dumpings before the end of the year, which could drive the share price lower and lower So, should we invest on ICO now??? Definitely, it will be up to everybody to make their own decision. For me, the answer is NO. This is ONLY my opinion. Do your own DD and make your investment wisely.




<< Previous
Bullboard Posts
Next >>